rituximab FDA approval date

The FDA approved rituximab (Rituxan) on 26 Nov 1997.

FDA approval date
26 Nov 1997

Drug identity checked against registry records

Also recorded as Rituxan

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin LymphomaNCT07477366IBRXPhase 2Not yet recruiting2027-12Estimated
Study of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesNCT07520006NRIXPhase 1, Phase 2Recruiting2033-05Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1997-11-26DayrituximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA103705", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["RITUXAN"], "active_ingredients": ["RITUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026